| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |